• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    High Drug Loading Amorphous Solid Dispersions

    Parenteral Drug Delivery Trends

    Selecting the Right Outsourcing Model for Emerging Biotech

    Inhaled Drug Delivery Technology

    The Future of Biologics: Accelerating Production, Reducing Costs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    J&J’s Single-Dose COVID-19 Vax Issued EUA

    Icon to Acquire PRA Health Sciences

    Phlow Corp. and USP Form Alliance

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    BMS Expands Cell Therapy Manufacturing Capabilities

    Novo Nordisk Invests $80M in Tablet Production

    Arcline Investment Acquires ChargePoint Technology

    Solid Dose Market Trends

    CatSci Opens New Site in UK
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reshaping the Pharmaceutical Supply Chain

    Covectra Introduces Next-Gen Serialization Solution

    Bormioli Opens New Glass Research Center

    Centrient Pharmaceuticals to Acquire Astral SteriTech

    Seasonal Vaccine Manufacturing
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Icon to Acquire PRA Health Sciences

    BMS Expands Cell Therapy Manufacturing Capabilities

    Ashfield Engage, Popit Form Digital Monitoring Collaboration

    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply

    CatSci Opens New Site in UK
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Alcami

    Emergent BioSolutions

    Cytovance Biologics

    Reed-Lane
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Cytovance Biologics

    Syngene

    Baxter BioPharma Solutions

    Adare Pharma Solutions

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    HPAPI Technology Trends

    Expanding HPAPI sector driving innovation in containment technology

    HPAPI Technology Trends
    Related CONTENT
    • Manufacturing Equipment Trends
    • Vetio Animal Health
    • HPAPI Equipment Advances
    • Outsourcing Strategies: Skills and Heritage
    • Asymchem Passes FDA Inspection at API Mfg. Site
    Michael Avraam, Global Product Manager, ChargePoint Technology10.10.18
    Use of high potency active pharmaceutical ingredients (HPAPIs) is increasing as pharmaceutical companies focus on developing more effective, better targeted medicines.

    This growing interest is increasing demand for the specialist handling and containment systems needed to ensure such products can be manufactured in a manner that complies with employee safety regulations.

    In addition, the trend has prompted manufacturers to search for faster, less labor intensive ways of verifying the efficacy of their containment systems.

    As a result, the interpretation of containment verification data has become a major focus for internal teams at drug companies and contract manufacturing organizations (CMOs).

    This article will outline some of the cutting edge handling and containment technologies being used to ensure the safety of pharmaceutical employees who work with HPAPIs. It will also outline validation and interpretation best practices industry leaders use to make sure their containment efforts are effective.

    HPAPI industry surge
    Demand for medicines that target and treat diseases more effectively and with fewer side effects has prompted many pharmaceutical manufacturers to invest in the development of HPAPI-based medicines.

    Analysis by Transparency Market Research suggests by the end of 2024 the cancer segment of the HPAPI market, the largest HPAPI segment by far, will be worth close to $100 billion in value, expanding at a CAGR of 6.5%.

    The term HPAPI is complicated. All active pharmaceutical ingredients have pharmacologic potency and each can be categorized on continuum of potency from low, to moderate and on to potent and highly potent.

    Substances categorized as potent or highly potent must be handled in accordance with strict criteria designed to protect people using them in pharmaceutical manufacture. Generally, HPAPIs are classified as being occupational exposure band 5 (OEB 5), which means staff who work with them must be exposed to less than 1µg/m³ within a working day. Limiting exposure to such a low level necessitates effective containment technologies.

    Containment tech in demand
    The use of isolators, restricted access barrier systems (RABS) and split butterfly valves (SBVs) that separate drug products from operators has grown significantly in recent years.

    Part of the reason for this is closed transfer technologies like the SBV limit manual intervention and reduce the risk of cross contamination. They also limit the presence of airborne dust particulates.

    Containment in the manufacturing environment
    Establishing effective containment systems in a pharmaceutical manufacturing environment is a considerable challenge because human intervention is present at almost every stage of manufacturing processes.

    It is therefore vitally important that containment solutions should not hinder operability or reduce productivity.

    Containment technologies such as SBVs have been developed to improve containment for processes where there is a risk of airborne exposure, including during all powder transfer stages.
    These valves, when integrated with isolators or other containment technologies, allow for material to be transferred without the risk of it escaping.

    Validation and assessment
    Once the desired handling and containment systems have been selected it is very important they are tested for efficacy. The best approach is to use a best practices checklist to make this assessment to prevent anything being overlooked.

    The International Society for Pharmaceutical Engineering’s (ISPE) SMEPAC (Standardized Measurement of Equipment Particulate Airborne Concentration) guideline is widely used. It outlines validation methodologies for a broad range of technologies and processing equipment, all of which are focused on assessing how well the system in question contains particulate matter. Specifically, it provides methodologies manufacturers can use to derive performance data that is invaluable for risk assessments.

    The SMEPAC guideline is just that, a guideline rather than a set of strict requirements. Nevertheless, it provides companies with a means of benchmarking their containment capabilities and provides a way of identifying potential risks.

    However, it is important to understand that the instructions and test methods set out in the guideline are conducted under controlled conditions in the laboratory. Effort must be made to understand how data generated during validation relates to real-world manufacturing.

    Data interpretation considerations
    The second phase of any containment technology validation process is data assessment and interpretation. Like all similar guidelines, the testing protocols set out in the SMEPAC document allow for a degree of inconsistency.

    For example, manufacturers often look at containment performance data and use it to qualify the selection of the required containment technology for their production process. However, it is important that variability in the testing methods for each type of technology is taken into consideration before any decisions are made.

    It is also important that validation testing takes the impact of operator intervention into consideration to ensure the containment device, some of which can be reliant on operator technique to achieve performance, is tested accordingly.

    Also, it is vital to keep in mind that all containment technologies used for a particular HPAPI-based pharmaceutical manufacturing process must be validated to ensure the performance of the system as a whole. Each step where there is potential exposure must be validated and the subject of a detailed risk assessment.

    The final stage of the validation process should also include the development of a preventative maintenance program based on areas of potential risk that are identified during the assessment phase. The idea is to look at the condition of each containment device and develop a maintenance plan that helps to safeguard the reliability of the containment solution.

    Integration and monitoring
    As illustrated above, validating containment technologies in a manufacturing environment where HPAPIs are used can be complex and very time consuming.

    One approach used to streamline this process is to select containment technologies with capacity for both continuous operational monitoring and the ability to communicate with other systems in place on the manufacturing line.

    A continuous flow of equipment operational data can shorten the time taken for revalidation of an existing line or indeed to develop a validation plan for new lines using duplicate technologies. This data can also provide insight into the wear and tear of equipment and therefore, when combined with containment testing results, allows users to secure a safe operating period or usage cycles for the valve before they begin to experience compromised performance. With this kind of monitoring, preventative maintenance can take place on a different level than before.

    A continuous monitoring approach is also a good fit for the ‘industry 4.0’ paradigm, which is based on the idea that Wi-Fi enabled components able to transmit data cut maintenance costs and allow problems to be quickly identified.

    Conclusion
    There are a huge range of factors a pharmaceutical firm must consider when working with HPAPIs. Containment is the most important consideration from a manufacturing standpoint as preventing these highly pharmacologically active substances injuring employees is critical.

    However, as stated above, it is also important the correct containment technologies and handling procedures are put in place and that all of these are validated in accordance with appropriated guidelines. Likewise, it is vital operations continue to be monitored for containment deviations after the process has been established and new wireless monitoring technology is set to make a real impact in terms of providing important operational performance data. 


    Michael Avraam is the global product manager at ChargePoint Technology for the PharmaSafe range of products. He is responsible for the development and evolution of ChargePoint’s split butterfly valve technology, including containment performance testing as well as developing new products and technologies.
    Related Searches
    • production
    • Testing
    • Validation
    • Development
    Suggested For You
    Manufacturing Equipment Trends Manufacturing Equipment Trends
    Vetio Animal Health Vetio Animal Health
    HPAPI Equipment Advances HPAPI Equipment Advances
    Outsourcing Strategies: Skills and Heritage Outsourcing Strategies: Skills and Heritage
    Asymchem Passes FDA Inspection at API Mfg. Site Asymchem Passes FDA Inspection at API Mfg. Site
    HPAPI Technology Evolution HPAPI Technology Evolution
    HPAPI Market Trends HPAPI Market Trends
    Finding the Right Partner Finding the Right Partner
    Catalent, Aucta Pharma Ink Commercial Mfg. Pact Catalent, Aucta Pharma Ink Commercial Mfg. Pact
    MilliporeSigma, InnoCore Partner on New Drug Delivery Technology  MilliporeSigma, InnoCore Partner on New Drug Delivery Technology
    10	Lilly 10 Lilly
    AGC Expands CDMO Services AGC Expands CDMO Services
    Semi-Solids: A Regulatory Perspective Semi-Solids: A Regulatory Perspective
    ChargePoint Launches Smart Monitoring Technology ChargePoint Launches Smart Monitoring Technology
    Ardena Strengthens API Offering Ardena Strengthens API Offering

    Related Features

    • Solid Dosage/Creams/Ointments
      High Drug Loading Amorphous Solid Dispersions

      High Drug Loading Amorphous Solid Dispersions

      A Novel Tablet Architecture for Amorphous Solid Dispersions to Achieve High Drug Loadings
      Deanna Mudie and Aaron Stewart, Lonza 01.27.21

    • Parenterals
      Parenteral Drug Delivery Trends

      Parenteral Drug Delivery Trends

      A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.
      Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

    • Selecting the Right Outsourcing Model for Emerging Biotech

      Selecting the Right Outsourcing Model for Emerging Biotech

      Flexible outsourcing models help drive quality, control costs and enable better efficiencies and faster delivery.
      Timothy King and Elisha Talley-Roithner, PPD 01.27.21


    • Drug Delivery
      Inhaled Drug Delivery Technology

      Inhaled Drug Delivery Technology

      The success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology being chosen for its delivery.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 01.27.21

    • Biologics, Proteins, Vaccines
      The Future of Biologics: Accelerating Production, Reducing Costs

      The Future of Biologics: Accelerating Production, Reducing Costs

      Yeast-based gene expression offers pharma the yield and efficiencies it needs to make pandemic-stopping vaccines faster and more economical.
      Mark Emalfarb, Dyadic 01.27.21

    • Analytical Services | Information Technology | Laboratory Testing
      Business Intelligence For (and From) the Lab

      Business Intelligence For (and From) the Lab

      How a digital ecosystem can harness the most data-rich environment in the CDMO.
      Bob Voelkner, VP Sales and Marketing, LabVantage 01.27.21


    • Communicating Your Contracting Priorities to Your Drug Company Customers

      Communicating Your Contracting Priorities to Your Drug Company Customers

      A discussion with Perrigo’s senior legal counsel, Susan Fyan, about issues that arise in very fact-specific contract negotiations between CDMOs and sponsors.
      Stephen Sayre, Dykema 01.27.21

    • COVID-19 Impact Report

      COVID-19 Impact Report

      Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.
      Tim Wright, Editor, Contract Pharma 01.27.21

    • Biologics, Proteins, Vaccines | Regulatory Affairs
      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

      A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to “normalcy.”
      Chad Landmon, Michelle Divelbiss and Alex Alfano, Attorneys - Axinn, Veltrop & Harkrider LLP 01.27.21


    • Excipients
      Bye-Bye China?

      Bye-Bye China?

      Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.
      Michele Jermini and Enrico Polastro 11.17.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20

    • Drug Delivery | Injectables
      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Self-Medication: Flexibility for Patients and Drug Manufacturers

      Bringing together self-medication with auto-injectors and sustainable secondary packaging.
      Matthias Heinrichs, Head of Product Management and Project Engineering, Syntegon Technology 11.17.20


    • The Single-Use Mixing Landscape: Evaluating Your Options

      The Single-Use Mixing Landscape: Evaluating Your Options

      Adoption of single-use technologies has increased markedly in recent years and will continue to grow.
      Mark A. Sitcoske, Founder & CEO, High Purity New England 11.17.20

    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      DCAT President Talks COVID-19, Drug Manufacturing and Innovation

      Lonza’s Director of Commercial Development, Sean Diver, was recently named President of DCAT.
      Tim Wright, Editor, Contract Pharma 11.17.20

    • Biologics, Proteins, Vaccines | Biosimilars | Drug Development
      Biopharma Contract Manufacturing: Robust Growth Ahead

      Biopharma Contract Manufacturing: Robust Growth Ahead

      The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
      William Downey, HighTech Business Decisions 11.17.20

    Trending
    • Bormioli Opens New Glass Research Center
    • Arcline Investment Acquires ChargePoint Technology
    • Spark Therapeutics Appoints CTO
    • The Future Of Vaccines And Biologics
    • BMS Expands Cell Therapy Manufacturing Capabilities
    Breaking News
    • J&J’s Single-Dose COVID-19 Vax Issued EUA
    • Icon to Acquire PRA Health Sciences
    • Phlow Corp. and USP Form Alliance
    • BMS Expands Cell Therapy Manufacturing Capabilities
    • Novo Nordisk Invests $80M in Tablet Production
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • High Drug Loading Amorphous Solid Dispersions
    • Parenteral Drug Delivery Trends
    • Selecting the Right Outsourcing Model for Emerging Biotech
    • Inhaled Drug Delivery Technology
    • The Future of Biologics: Accelerating Production, Reducing Costs
    • Business Intelligence For (and From) the Lab
    • Communicating Your Contracting Priorities to Your Drug Company Customers
    • COVID-19 Impact Report
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Gelest CEO Elected to National Academy of Engineering
    PPG Appoints Tony Wu as VP, Automotive Refinish, Asia
    PPG Appoints John Bruno as VP, Investor Relations
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Nurx Appoints Chief Medical Officer
    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    Contract Pharma

    Latest Breaking News From Contract Pharma

    J&J’s Single-Dose COVID-19 Vax Issued EUA
    Icon to Acquire PRA Health Sciences
    Phlow Corp. and USP Form Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Supporting Female Beauty Brand Founders on International Women's Day
    Happi

    Latest Breaking News From Happi

    ACI and CBC Launch Webpage About ‘Quats’
    L’Occitane Launches Hand Cream Inspired by Women
    Kiehl’s Partners with Gyrl Wonder
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI analyzes pandemic's effect on label industry in new report
    UEI names Ross Hutchison president
    Schreiner MediPharm and AARDEX partner for clinical trials
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    U.S. Nonwovens Rebrands as Radienz Living
    What You’re Reading on Nonwovens-Industry.com
    Texas Medical Technology Partners with My Protect Kit
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Pandemic Pain: NuVasive's 2020 Sales Fall 10 Percent
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login